Occudo Quantitative Strategies LP Acquires Shares of 4,711 Trupanion, Inc. (NASDAQ:TRUP)

Occudo Quantitative Strategies LP acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,711 shares of the financial services provider’s stock, valued at approximately $227,000.

Several other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. grew its holdings in Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock valued at $173,362,000 after purchasing an additional 45,653 shares during the period. Marshall Wace LLP grew its holdings in Trupanion by 6.9% in the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock valued at $43,459,000 after purchasing an additional 57,804 shares during the period. Balyasny Asset Management L.P. grew its holdings in Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock valued at $40,548,000 after purchasing an additional 661,559 shares during the period. Baillie Gifford & Co. lifted its position in shares of Trupanion by 26.6% in the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock valued at $33,806,000 after acquiring an additional 147,341 shares in the last quarter. Finally, Northern Trust Corp lifted its position in shares of Trupanion by 9.0% in the fourth quarter. Northern Trust Corp now owns 368,236 shares of the financial services provider’s stock valued at $17,749,000 after acquiring an additional 30,549 shares in the last quarter.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the transaction, the chief executive officer now owns 118,784 shares in the company, valued at approximately $3,728,629.76. This trade represents a 1.89% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of Trupanion stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now owns 2,416 shares in the company, valued at $82,675.52. This represents a 36.24% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,792 shares of company stock worth $1,122,802. 5.42% of the stock is owned by corporate insiders.

Trupanion Stock Performance

Shares of Trupanion stock opened at $46.77 on Friday. Trupanion, Inc. has a one year low of $25.90 and a one year high of $57.90. The company has a market cap of $2.00 billion, a price-to-earnings ratio of -203.35, a PEG ratio of 6.02 and a beta of 1.72. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The business’s 50 day moving average price is $37.96 and its 200 day moving average price is $44.27.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same quarter last year, the business posted ($0.16) earnings per share. The firm’s revenue was up 11.7% compared to the same quarter last year. On average, research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on TRUP shares. Lake Street Capital decreased their target price on Trupanion from $65.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, May 2nd. Stifel Nicolaus decreased their target price on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research report on Thursday, February 20th. Finally, Piper Sandler decreased their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a research report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $51.80.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.